aluates Reports

$ 0.0

Automative

Global Non-Oncology Precision Medicine Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-30T3642

Global Non Oncology Precision Medicine Market Insights Forecast to 2028

BUY CHAPTERS

Global Non-Oncology Precision Medicine Market Research Report 2025

Code: QYRE-Auto-30T3642

Report

June 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott Laboratories

Agilent Technologies Inc

Asuragen

Almac Group

Astrazeneca plc

Bristol–Myers Squibb

BioMérieux SA

BGI

Danaher Corp

Illumina Inc

Invitae Corporation

OPKO Health Inc

Teva Pharmaceutical Industries Ltd

Non-Oncology Precision Medicine Market Size

The global market for Non-Oncology Precision Medicine was valued at US$ 89900 million in the year 2024 and is projected to reach a revised size of US$ 120220 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Non-Oncology Precision Medicine Market

In the non-oncology precision medicine market, the application of molecular biology is to study the etiology of diseases other than cancer at the molecular level, so target-based therapy or individualized therapy can be used to cure patients" health-related problems.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Non-Oncology Precision Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Oncology Precision Medicine.

The Non-Oncology Precision Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Oncology Precision Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-Oncology Precision Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-Oncology Precision Medicine Market Report

Report Metric	Details
Report Name	Non-Oncology Precision Medicine Market
Accounted market size in year	US$ 89900 million
Forecasted market size in 2031	US$ 120220 million
CAGR	4.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Applied Sciences Precision Diagnostics Digital Health and Information Technology Precision Therapeutics
Segment by Application	Infectious Diseases Neurology Cardiovascular Lifestyle and Endocrinology Gastroenterology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Agilent Technologies, Inc., Asuragen, Inc., Almac Group, AstraZeneca PLC, Bristol Myers Squibb, bioMérieux SA., BGI, Danaher Corp., Illumina, Inc., Invitae Corporation, Opko Health, Inc., Teva Pharmaceutical Industries Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Oncology Precision Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Non-Oncology Precision Medicine Market growing?

Ans: The Non-Oncology Precision Medicine Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Non-Oncology Precision Medicine Market size in 2031?

Ans: The Non-Oncology Precision Medicine Market size in 2031 will be US$ 120220 million.

What is the Non-Oncology Precision Medicine Market share by application?

Ans: The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets.

Who are the main players in the Non-Oncology Precision Medicine Market report?

Ans: The main players in the Non-Oncology Precision Medicine Market are Abbott Laboratories, Agilent Technologies, Inc., Asuragen, Inc., Almac Group, AstraZeneca PLC, Bristol Myers Squibb, bioMérieux SA., BGI, Danaher Corp., Illumina, Inc., Invitae Corporation, Opko Health, Inc., Teva Pharmaceutical Industries Ltd.

What are the Application segmentation covered in the Non-Oncology Precision Medicine Market report?

Ans: The Applications covered in the Non-Oncology Precision Medicine Market report are Infectious Diseases, Neurology, Cardiovascular, Lifestyle and Endocrinology, Gastroenterology, Others

What are the Type segmentation covered in the Non-Oncology Precision Medicine Market report?

Ans: The Types covered in the Non-Oncology Precision Medicine Market report are Applied Sciences, Precision Diagnostics, Digital Health and Information Technology, Precision Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-Oncology Precision Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Applied Sciences

1.2.3 Precision Diagnostics

1.2.4 Digital Health and Information Technology

1.2.5 Precision Therapeutics

1.3 Market by Application

1.3.1 Global Non-Oncology Precision Medicine Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Infectious Diseases

1.3.3 Neurology

1.3.4 Cardiovascular

1.3.5 Lifestyle and Endocrinology

1.3.6 Gastroenterology

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-Oncology Precision Medicine Market Perspective (2020-2031)

2.2 Global Non-Oncology Precision Medicine Growth Trends by Region

2.2.1 Global Non-Oncology Precision Medicine Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Non-Oncology Precision Medicine Historic Market Size by Region (2020-2025)

2.2.3 Non-Oncology Precision Medicine Forecasted Market Size by Region (2026-2031)

2.3 Non-Oncology Precision Medicine Market Dynamics

2.3.1 Non-Oncology Precision Medicine Industry Trends

2.3.2 Non-Oncology Precision Medicine Market Drivers

2.3.3 Non-Oncology Precision Medicine Market Challenges

2.3.4 Non-Oncology Precision Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-Oncology Precision Medicine Players by Revenue

3.1.1 Global Top Non-Oncology Precision Medicine Players by Revenue (2020-2025)

3.1.2 Global Non-Oncology Precision Medicine Revenue Market Share by Players (2020-2025)

3.2 Global Non-Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Non-Oncology Precision Medicine Revenue

3.4 Global Non-Oncology Precision Medicine Market Concentration Ratio

3.4.1 Global Non-Oncology Precision Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-Oncology Precision Medicine Revenue in 2024

3.5 Global Key Players of Non-Oncology Precision Medicine Head office and Area Served

3.6 Global Key Players of Non-Oncology Precision Medicine, Product and Application

3.7 Global Key Players of Non-Oncology Precision Medicine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Oncology Precision Medicine Breakdown Data by Type

4.1 Global Non-Oncology Precision Medicine Historic Market Size by Type (2020-2025)

4.2 Global Non-Oncology Precision Medicine Forecasted Market Size by Type (2026-2031)

5 Non-Oncology Precision Medicine Breakdown Data by Application

5.1 Global Non-Oncology Precision Medicine Historic Market Size by Application (2020-2025)

5.2 Global Non-Oncology Precision Medicine Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Non-Oncology Precision Medicine Market Size (2020-2031)

6.2 North America Non-Oncology Precision Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Non-Oncology Precision Medicine Market Size by Country (2020-2025)

6.4 North America Non-Oncology Precision Medicine Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-Oncology Precision Medicine Market Size (2020-2031)

7.2 Europe Non-Oncology Precision Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Non-Oncology Precision Medicine Market Size by Country (2020-2025)

7.4 Europe Non-Oncology Precision Medicine Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-Oncology Precision Medicine Market Size (2020-2031)

8.2 Asia-Pacific Non-Oncology Precision Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Non-Oncology Precision Medicine Market Size by Region (2020-2025)

8.4 Asia-Pacific Non-Oncology Precision Medicine Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-Oncology Precision Medicine Market Size (2020-2031)

9.2 Latin America Non-Oncology Precision Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Non-Oncology Precision Medicine Market Size by Country (2020-2025)

9.4 Latin America Non-Oncology Precision Medicine Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-Oncology Precision Medicine Market Size (2020-2031)

10.2 Middle East & Africa Non-Oncology Precision Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Non-Oncology Precision Medicine Market Size by Country (2020-2025)

10.4 Middle East & Africa Non-Oncology Precision Medicine Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Non-Oncology Precision Medicine Introduction

11.1.4 Abbott Laboratories Revenue in Non-Oncology Precision Medicine Business (2020-2025)

11.1.5 Abbott Laboratories Recent Development

11.2 Agilent Technologies, Inc.

11.2.1 Agilent Technologies, Inc. Company Details

11.2.2 Agilent Technologies, Inc. Business Overview

11.2.3 Agilent Technologies, Inc. Non-Oncology Precision Medicine Introduction

11.2.4 Agilent Technologies, Inc. Revenue in Non-Oncology Precision Medicine Business (2020-2025)

11.2.5 Agilent Technologies, Inc. Recent Development

11.3 Asuragen, Inc.

11.3.1 Asuragen, Inc. Company Details

11.3.2 Asuragen, Inc. Business Overview

11.3.3 Asuragen, Inc. Non-Oncology Precision Medicine Introduction

11.3.4 Asuragen, Inc. Revenue in Non-Oncology Precision Medicine Business (2020-2025)

11.3.5 Asuragen, Inc. Recent Development

11.4 Almac Group

11.4.1 Almac Group Company Details

11.4.2 Almac Group Business Overview

11.4.3 Almac Group Non-Oncology Precision Medicine Introduction

11.4.4 Almac Group Revenue in Non-Oncology Precision Medicine Business (2020-2025)

11.4.5 Almac Group Recent Development

11.5 AstraZeneca PLC

11.5.1 AstraZeneca PLC Company Details

11.5.2 AstraZeneca PLC Business Overview

11.5.3 AstraZeneca PLC Non-Oncology Precision Medicine Introduction

11.5.4 AstraZeneca PLC Revenue in Non-Oncology Precision Medicine Business (2020-2025)

11.5.5 AstraZeneca PLC Recent Development

11.6 Bristol Myers Squibb

11.6.1 Bristol Myers Squibb Company Details

11.6.2 Bristol Myers Squibb Business Overview

11.6.3 Bristol Myers Squibb Non-Oncology Precision Medicine Introduction

11.6.4 Bristol Myers Squibb Revenue in Non-Oncology Precision Medicine Business (2020-2025)

11.6.5 Bristol Myers Squibb Recent Development

11.7 bioMérieux SA.

11.7.1 bioMérieux SA. Company Details

11.7.2 bioMérieux SA. Business Overview

11.7.3 bioMérieux SA. Non-Oncology Precision Medicine Introduction

11.7.4 bioMérieux SA. Revenue in Non-Oncology Precision Medicine Business (2020-2025)

11.7.5 bioMérieux SA. Recent Development

11.8 BGI

11.8.1 BGI Company Details

11.8.2 BGI Business Overview

11.8.3 BGI Non-Oncology Precision Medicine Introduction

11.8.4 BGI Revenue in Non-Oncology Precision Medicine Business (2020-2025)

11.8.5 BGI Recent Development

11.9 Danaher Corp.

11.9.1 Danaher Corp. Company Details

11.9.2 Danaher Corp. Business Overview

11.9.3 Danaher Corp. Non-Oncology Precision Medicine Introduction

11.9.4 Danaher Corp. Revenue in Non-Oncology Precision Medicine Business (2020-2025)

11.9.5 Danaher Corp. Recent Development

11.10 Illumina, Inc.

11.10.1 Illumina, Inc. Company Details

11.10.2 Illumina, Inc. Business Overview

11.10.3 Illumina, Inc. Non-Oncology Precision Medicine Introduction

11.10.4 Illumina, Inc. Revenue in Non-Oncology Precision Medicine Business (2020-2025)

11.10.5 Illumina, Inc. Recent Development

11.11 Invitae Corporation

11.11.1 Invitae Corporation Company Details

11.11.2 Invitae Corporation Business Overview

11.11.3 Invitae Corporation Non-Oncology Precision Medicine Introduction

11.11.4 Invitae Corporation Revenue in Non-Oncology Precision Medicine Business (2020-2025)

11.11.5 Invitae Corporation Recent Development

11.12 Opko Health, Inc.

11.12.1 Opko Health, Inc. Company Details

11.12.2 Opko Health, Inc. Business Overview

11.12.3 Opko Health, Inc. Non-Oncology Precision Medicine Introduction

11.12.4 Opko Health, Inc. Revenue in Non-Oncology Precision Medicine Business (2020-2025)

11.12.5 Opko Health, Inc. Recent Development

11.13 Teva Pharmaceutical Industries Ltd.

11.13.1 Teva Pharmaceutical Industries Ltd. Company Details

11.13.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.13.3 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Introduction

11.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Non-Oncology Precision Medicine Business (2020-2025)

11.13.5 Teva Pharmaceutical Industries Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott Laboratories

Agilent Technologies Inc

Asuragen

Almac Group

Astrazeneca plc

Bristol–Myers Squibb

BioMérieux SA

BGI

Danaher Corp

Illumina Inc

Invitae Corporation

OPKO Health Inc

Teva Pharmaceutical Industries Ltd

List of Tables

Table 1. Global Non-Oncology Precision Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Applied Sciences

Table 3. Key Players of Precision Diagnostics

Table 4. Key Players of Digital Health and Information Technology

Table 5. Key Players of Precision Therapeutics

Table 6. Global Non-Oncology Precision Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Non-Oncology Precision Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Non-Oncology Precision Medicine Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Non-Oncology Precision Medicine Market Share by Region (2020-2025)

Table 10. Global Non-Oncology Precision Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Non-Oncology Precision Medicine Market Share by Region (2026-2031)

Table 12. Non-Oncology Precision Medicine Market Trends

Table 13. Non-Oncology Precision Medicine Market Drivers

Table 14. Non-Oncology Precision Medicine Market Challenges

Table 15. Non-Oncology Precision Medicine Market Restraints

Table 16. Global Non-Oncology Precision Medicine Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Non-Oncology Precision Medicine Market Share by Players (2020-2025)

Table 18. Global Top Non-Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Oncology Precision Medicine as of 2024)

Table 19. Ranking of Global Top Non-Oncology Precision Medicine Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Non-Oncology Precision Medicine Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Non-Oncology Precision Medicine, Headquarters and Area Served

Table 22. Global Key Players of Non-Oncology Precision Medicine, Product and Application

Table 23. Global Key Players of Non-Oncology Precision Medicine, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Non-Oncology Precision Medicine Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Non-Oncology Precision Medicine Revenue Market Share by Type (2020-2025)

Table 27. Global Non-Oncology Precision Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Non-Oncology Precision Medicine Revenue Market Share by Type (2026-2031)

Table 29. Global Non-Oncology Precision Medicine Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Non-Oncology Precision Medicine Revenue Market Share by Application (2020-2025)

Table 31. Global Non-Oncology Precision Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Non-Oncology Precision Medicine Revenue Market Share by Application (2026-2031)

Table 33. North America Non-Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Non-Oncology Precision Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Non-Oncology Precision Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Non-Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Non-Oncology Precision Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Non-Oncology Precision Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Non-Oncology Precision Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Non-Oncology Precision Medicine Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Non-Oncology Precision Medicine Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Non-Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Non-Oncology Precision Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Non-Oncology Precision Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Non-Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Non-Oncology Precision Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Non-Oncology Precision Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 48. Abbott Laboratories Company Details

Table 49. Abbott Laboratories Business Overview

Table 50. Abbott Laboratories Non-Oncology Precision Medicine Product

Table 51. Abbott Laboratories Revenue in Non-Oncology Precision Medicine Business (2020-2025) & (US$ Million)

Table 52. Abbott Laboratories Recent Development

Table 53. Agilent Technologies, Inc. Company Details

Table 54. Agilent Technologies, Inc. Business Overview

Table 55. Agilent Technologies, Inc. Non-Oncology Precision Medicine Product

Table 56. Agilent Technologies, Inc. Revenue in Non-Oncology Precision Medicine Business (2020-2025) & (US$ Million)

Table 57. Agilent Technologies, Inc. Recent Development

Table 58. Asuragen, Inc. Company Details

Table 59. Asuragen, Inc. Business Overview

Table 60. Asuragen, Inc. Non-Oncology Precision Medicine Product

Table 61. Asuragen, Inc. Revenue in Non-Oncology Precision Medicine Business (2020-2025) & (US$ Million)

Table 62. Asuragen, Inc. Recent Development

Table 63. Almac Group Company Details

Table 64. Almac Group Business Overview

Table 65. Almac Group Non-Oncology Precision Medicine Product

Table 66. Almac Group Revenue in Non-Oncology Precision Medicine Business (2020-2025) & (US$ Million)

Table 67. Almac Group Recent Development

Table 68. AstraZeneca PLC Company Details

Table 69. AstraZeneca PLC Business Overview

Table 70. AstraZeneca PLC Non-Oncology Precision Medicine Product

Table 71. AstraZeneca PLC Revenue in Non-Oncology Precision Medicine Business (2020-2025) & (US$ Million)

Table 72. AstraZeneca PLC Recent Development

Table 73. Bristol Myers Squibb Company Details

Table 74. Bristol Myers Squibb Business Overview

Table 75. Bristol Myers Squibb Non-Oncology Precision Medicine Product

Table 76. Bristol Myers Squibb Revenue in Non-Oncology Precision Medicine Business (2020-2025) & (US$ Million)

Table 77. Bristol Myers Squibb Recent Development

Table 78. bioMérieux SA. Company Details

Table 79. bioMérieux SA. Business Overview

Table 80. bioMérieux SA. Non-Oncology Precision Medicine Product

Table 81. bioMérieux SA. Revenue in Non-Oncology Precision Medicine Business (2020-2025) & (US$ Million)

Table 82. bioMérieux SA. Recent Development

Table 83. BGI Company Details

Table 84. BGI Business Overview

Table 85. BGI Non-Oncology Precision Medicine Product

Table 86. BGI Revenue in Non-Oncology Precision Medicine Business (2020-2025) & (US$ Million)

Table 87. BGI Recent Development

Table 88. Danaher Corp. Company Details

Table 89. Danaher Corp. Business Overview

Table 90. Danaher Corp. Non-Oncology Precision Medicine Product

Table 91. Danaher Corp. Revenue in Non-Oncology Precision Medicine Business (2020-2025) & (US$ Million)

Table 92. Danaher Corp. Recent Development

Table 93. Illumina, Inc. Company Details

Table 94. Illumina, Inc. Business Overview

Table 95. Illumina, Inc. Non-Oncology Precision Medicine Product

Table 96. Illumina, Inc. Revenue in Non-Oncology Precision Medicine Business (2020-2025) & (US$ Million)

Table 97. Illumina, Inc. Recent Development

Table 98. Invitae Corporation Company Details

Table 99. Invitae Corporation Business Overview

Table 100. Invitae Corporation Non-Oncology Precision Medicine Product

Table 101. Invitae Corporation Revenue in Non-Oncology Precision Medicine Business (2020-2025) & (US$ Million)

Table 102. Invitae Corporation Recent Development

Table 103. Opko Health, Inc. Company Details

Table 104. Opko Health, Inc. Business Overview

Table 105. Opko Health, Inc. Non-Oncology Precision Medicine Product

Table 106. Opko Health, Inc. Revenue in Non-Oncology Precision Medicine Business (2020-2025) & (US$ Million)

Table 107. Opko Health, Inc. Recent Development

Table 108. Teva Pharmaceutical Industries Ltd. Company Details

Table 109. Teva Pharmaceutical Industries Ltd. Business Overview

Table 110. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product

Table 111. Teva Pharmaceutical Industries Ltd. Revenue in Non-Oncology Precision Medicine Business (2020-2025) & (US$ Million)

Table 112. Teva Pharmaceutical Industries Ltd. Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Non-Oncology Precision Medicine Picture

Figure 2. Global Non-Oncology Precision Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Non-Oncology Precision Medicine Market Share by Type: 2024 VS 2031

Figure 4. Applied Sciences Features

Figure 5. Precision Diagnostics Features

Figure 6. Digital Health and Information Technology Features

Figure 7. Precision Therapeutics Features

Figure 8. Global Non-Oncology Precision Medicine Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Non-Oncology Precision Medicine Market Share by Application: 2024 VS 2031

Figure 10. Infectious Diseases Case Studies

Figure 11. Neurology Case Studies

Figure 12. Cardiovascular Case Studies

Figure 13. Lifestyle and Endocrinology Case Studies

Figure 14. Gastroenterology Case Studies

Figure 15. Others Case Studies

Figure 16. Non-Oncology Precision Medicine Report Years Considered

Figure 17. Global Non-Oncology Precision Medicine Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Non-Oncology Precision Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Non-Oncology Precision Medicine Market Share by Region: 2024 VS 2031

Figure 20. Global Non-Oncology Precision Medicine Market Share by Players in 2024

Figure 21. Global Top Non-Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Oncology Precision Medicine as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Non-Oncology Precision Medicine Revenue in 2024

Figure 23. North America Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Non-Oncology Precision Medicine Market Share by Country (2020-2031)

Figure 25. United States Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Non-Oncology Precision Medicine Market Share by Country (2020-2031)

Figure 29. Germany Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Non-Oncology Precision Medicine Market Share by Region (2020-2031)

Figure 37. China Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Non-Oncology Precision Medicine Market Share by Country (2020-2031)

Figure 45. Mexico Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Non-Oncology Precision Medicine Market Share by Country (2020-2031)

Figure 49. Turkey Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Non-Oncology Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Abbott Laboratories Revenue Growth Rate in Non-Oncology Precision Medicine Business (2020-2025)

Figure 53. Agilent Technologies, Inc. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2020-2025)

Figure 54. Asuragen, Inc. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2020-2025)

Figure 55. Almac Group Revenue Growth Rate in Non-Oncology Precision Medicine Business (2020-2025)

Figure 56. AstraZeneca PLC Revenue Growth Rate in Non-Oncology Precision Medicine Business (2020-2025)

Figure 57. Bristol Myers Squibb Revenue Growth Rate in Non-Oncology Precision Medicine Business (2020-2025)

Figure 58. bioMérieux SA. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2020-2025)

Figure 59. BGI Revenue Growth Rate in Non-Oncology Precision Medicine Business (2020-2025)

Figure 60. Danaher Corp. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2020-2025)

Figure 61. Illumina, Inc. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2020-2025)

Figure 62. Invitae Corporation Revenue Growth Rate in Non-Oncology Precision Medicine Business (2020-2025)

Figure 63. Opko Health, Inc. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2020-2025)

Figure 64. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Personalized Precision Medicine Market Research Report 2024

Precision Medicine Diagnostics Market

Global Non Hematological Cancer Treatment Market Research Report 2024

Global Personalized Cancer Medicine Market Research Report 2025

Global Non Hematological Cancers Market Research Report 2024

Global Non invasive Cancer Diagnosis Market Research Report 2024

Artificial Intelligence AI in Precision Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Precision Medicine Research and Development Platform Market Research Report 2024

Global Alternative Medicines and Therapy Market Research Report 2024

Global Molecular Oncology Market Research Report 2024

Global Non oncology Biopharmaceuticals Market Insights Forecast to 2030

Precision Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oncology Precision Medicine Market

Global Non Melanoma Skin Cancer Treatment Market Research Report 2024

Global Smart Precision Medicine Software Market Insights Forecast to 2030

Global Personalized Medicines In Oncology Market Research Report 2024

Global Precision Psychiatry Market Research Report 2024

Global Non Opioid Pain Treatment Market Insights Forecast to 2030

Global Non Melanoma Skin Cancer Market Research Report 2024

RELATED REPORTS

Global Ultrasonics Technologies Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0L6392

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Health Self-monitoring Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4V7252

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global High-Acuity Information System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4O6282

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Marburgvirus Infection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36D6023

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions